Kerry Clem is the Chief Commercial Officer at Acorda Therapeutics, a biotechnology company developing new treatments for neurological conditions.
In this role, Clem is responsible for leading the Sales, Marketing, Market Access, Commercial Strategy, Commercial Operations, and Digital Strategy teams. He is also a member of Acorda’s Executive Leadership Team, helping to set the company’s strategic and operational direction.
During his ten plus year tenure at Acorda, Clem has helped steer the company’s growth through the commercial success of its products for multiple sclerosis and Parkinson’s disease.
Clem has spent decades in the biotech industry in progressive leadership roles, working with private and public start-up and high growth organizations. He was the architect of many high performing commercial teams before joining Acorda. Clem has been a champion of inclusion – motivating others to become the best version of themselves.
Clem was a founding member of the Acorda mentorship program and has previously helped facilitate a program to encourage minority graduates at HBCUs (Historically Black Colleges and Universities) to pursue careers in the biopharmaceutical industry.
Clem holds a Bachelor of Science degree from Florida State University.
